Browse News
Filter News
Found 512,558 articles
-
Evotec AG and Haplogen GmbH have been long-term collaboration partners. The companies announced that Haplogen will enter into a multi-year drug discovery and development deal with Bayer AG to focus on pulmonary diseases like chronic obstructive pulmonary disease (COPD).
-
Shares of Realm Therapeutics have plunged more than 50 percent this morning after the company announced its Phase II atopic dermatitis drug failed to distinguish itself from the control arm in the trial.
-
As Novartis wrangles with the fallout from its association with Michael Cohen and the fees it paid his consulting company for access to the administration of President Donald Trump, the Swiss pharma giant has brought on a new chief ethics officer.
-
Acorda Therapeutics Chief Technology Officer Rick Batycky is leaving the company to take over the helm of an unnamed biotechnology company.
-
Gene therapy has been a dream for many researchers for decades—inserting a healthier gene into patients’ cells to replace defective genes and curing diseases. One disease that would seem to be a good target for gene therapy is hemophilia.
-
Western government agencies have been warning of an increase in cyber espionage from nefarious black hats and governments for years. The targets have typically been government and financial installations. But a new warning suggests that biotechnology could be a key target for cyber hackers.
-
Mustang Bio and St. Jude Children’s Research Hospital have signed an exclusive worldwide license deal to develop a first-in-class lentiviral gene therapy for X-linked severe combined immunodeficiency (X-SCID).
-
Massachusetts in general and Boston, specifically Cambridge, is one of the two largest centers in the U.S. for biotech startups and life science companies (the other being the San Francisco Bay Area). Here’s a look at 13 Massachusetts life science companies that are showing both gains and losses—...
-
Realm Therapeutics Reports Top-line Data from Phase 2 Trial of PR022 in Atopic Dermatitis and First Half 2018 Financial Results
8/14/2018
In a randomized, double-blind, vehicle controlled, Phase 2 clinical trial of 122 patients, PR022 showed no difference from vehicle in the primary endpoint of percent change in Eczema Area Severity Index (EASI) versus baseline.
-
Inova Diagnostics Receives FDA Clearance for Test to Detect Antibodies to HMGCR
8/14/2018
HMGCR is a marker exclusively available from Inova Diagnostics, and is one of 30 FDA-cleared assays available on BIO-FLASH®, a random access chemiluminescent system
-
CVS Health Survey Finds Consumers More Likely to Get Vaccinated Following Last Year's Record Breaking Flu Season
8/14/2018
22 percent of those surveyed say that knowledge of last year's severe flu season makes them more likely to get a flu shot this year
-
GlycoMimetics Receives Japanese Patent For Uproleselan (GMI-1271)
8/14/2018
Issued patent expands global patent portfolio for GlycoMimetics’ late-stage drug candidate targeting treatment of broad spectrum of patients with acute myeloid leukemia
-
DASH Analytics High Definition Care Platform Chosen for CDC Epicenter Trial in Surgical Site Infection
8/14/2018
The multicenter trial will assess the efficacy of using negative pressure wound therapy in preventing surgical site infections.
-
Entasis Therapeutics Announces Positive Topline Results from Phase 2 Trial of ETX2514SUL in Patients with Complicated Urinary Tract Infections including Acute Pyelonephritis
8/14/2018
ETX2514SUL was generally well tolerated
-
NBC News' Today Show Features Medical Marijuana, Inc. CBD Body Care Products
8/14/2018
Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States, today announced that it has garnered national news coverage on NBC News' TODAY Show for its cannabidiol (CBD) body care products.
-
Correvio Announces Brinavess Selected as Potentially Eligible for Priority Review in China
8/14/2018
Brinavess Named One of 48 Drugs Deemed Clinically Urgent and Targeted for Expedited Clearance Based on Existing Ex-China Clinical Data
-
Terves and Powdermet Provide Semi-Annual Update
8/14/2018
As we complete the first half of 2018, we would like to thank all our customers, employees, stakeholders for their continued effort and support for Terves and Powdermet’s products and technologies.
-
The Buck Institute, Insilico Medicine, and Juvenescence Found Napa Therapeutics to Develop Drugs to Impede Age-Related Disease
8/14/2018
Collaboration will harness AI technology to address an aging-related target.
-
Nu-Med Plus, Inc. Strategically Positioned After Monopoly-Ending Patent Ruling Opens Nitric Oxide Market
8/14/2018
Innovative nitric oxide delivery device company predicting vibrant market for its next-generation products.
-
Procleix® Zika Virus Assay Approved by the FDA for Blood Screening on the Procleix® Panther® System
8/14/2018
Procleix Zika Virus assay approved for the detection of viral RNA in plasma and serum specimens, previously used since June 2016 under IND protocol.